8.03
price up icon5.38%   0.41
after-market Handel nachbörslich: 8.14 0.11 +1.37%
loading

Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten

pulisher
Jun 18, 2025

Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 18, 2025

Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Sagimet stock holds steady as JMP reiterates $31 price target By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 17, 2025

Sagimet Biosciences Inc: Analyzing SGMT Stock Trends - investchronicle.com

Jun 17, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Trims Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Sagimet Biosciences updates executive compensation By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Sagimet Biosciences updates executive compensation - Investing.com

Jun 10, 2025
pulisher
Jun 10, 2025

Sagimet Biosciences Elects New Directors at Annual Meeting - TipRanks

Jun 10, 2025
pulisher
Jun 09, 2025

Sagimet Biosciences to Host Virtual KOL Event, “A New - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

Sagimet Biosciences to host KOL event on denifanstat results - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Sagimet Biosciences (SGMT) to Highlight Positive Phase 3 Acne Treatment Results | SGMT Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Sagimet Biosciences to Host Virtual KOL Event, 'A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025 - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025 - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

Breakthrough Phase 3 Results: Novel Oral Acne Drug Shows Promise for 50M US Patients - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

Analysts Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $23.17 - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Grows Stake in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Sagimet Biosciences (NASDAQ:SGMT) Stock Price Expected to Rise, Jones Trading Analyst Says - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Sagimet Biosciences (SGMT) Price Target Raised by Jones Trading - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Sagimet Biosciences (SGMT) Price Target Raised by Jones Trading | SGMT Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Sagimet Biosciences Shares Surge After Promising Phase 3 Acne Drug Results - MSN

Jun 06, 2025
pulisher
Jun 05, 2025

Sagimet Biosciences price target raised to $27 from $15 at JonesResearch - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Sagimet Biosciences (SGMT) Target Price Raised to $27 by Analyst | SGMT Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Uncovering Hidden Gems: Penny Stocks To Consider In June 2025 - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

Jane Street Group LLC Purchases New Stake in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Promising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Sagimet: Positive China Partner Acne Vulgaris Data Bodes Well For TVB-3567 (SGMT) - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

leerink partners maintains outperform rating on sagimet stock By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences (SGMT) Surges on Successful Acne Drug Trial in China - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet partner Ascletis announces significant Phase III acne data - The Pharma Letter

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care - MarketScreener

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Acne Trial In China, Stock Jumps - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

leerink partners maintains outperform rating on sagimet stock - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences shares soar on positive acne treatment trial results By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences shares soar on positive acne treatment trial results - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet stock climbs on acne trial data (SGMT:NASDAQ) - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences Announces Phase 3 Trial Success - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences Announces Positive Phase 3 Results for - GlobeNewswire

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences Says Acne Vulgaris Treatment Meets Phase 3 Trial Primary, Secondary Endpoints - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences Announces Positive Phase 3 Results For Denifanstat - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sagimet Biosciences Reports Successful Phase 3 Results for Denifanstat in Moderate to Severe Acne and Initiates Phase 1 Trial for TVB-3567 - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Breakthrough Acne Treatment Achieves Phase 3 Success: First New Oral Drug Mechanism in 40 Years Shows Promise - Stock Titan

Jun 04, 2025
pulisher
May 22, 2025

Sagimet Biosciences’ SWOT analysis: denifanstat’s potential in MASH treatment - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Sagimet Biosciences’ SWOT analysis: denifanstat’s potential in MASH treatment By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Sagimet Biosciences to host KOL event on denifanstat, resmetirom - TipRanks

May 22, 2025
pulisher
May 22, 2025

Sagimet Biosciences (SGMT) to Host Key Opinion Leader Event on I - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Sagimet Biosciences to Host Virtual KOL Event, “Evaluating - GlobeNewswire

May 22, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Kapitalisierung:     |  Volumen (24h):